|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.150 USD | -2.54% |
|
-20.14% | -81.21% |
| 06-29 | Actuate Therapeutics, Inc.(NasdaqGM:ACTU) dropped from Russell 2000 Dynamic Index | CI |
| 06-29 | Actuate Therapeutics, Inc.(NasdaqGM:ACTU) dropped from Russell 3000E Index | CI |
| Market Cap | 28.23M 24.82M 23.1M 21.22M 39.84M 2.71B 40.37M 275M 107M 1.34B 106M 104M 4.62B | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 28.23M 24.82M 23.1M 21.22M 39.84M 2.71B 40.37M 275M 107M 1.34B 106M 104M 4.62B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | - |
| Free-Float |
85.17% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | -2.54% | ||
| 1 week | -20.14% | ||
| Current month | -24.84% | ||
| 1 month | -31.55% | ||
| 3 months | -61.28% | ||
| 6 months | -78.64% | ||
| Current year | -81.21% |
| 1 week | 1.11 |  | 1.5 |
| 1 month | 1.11 | | 1.95 |
| Current year | 1.11 | | 7.05 |
| 1 year | 1.11 | | 9.22 |
| 3 years | 1.11 | | 11.99 |
| 5 years | 1.11 | | 11.99 |
| 10 years | 1.11 | | 11.99 |
| Manager | Title | Age | Since |
|---|---|---|---|
Daniel Schmitt
CEO | Chief Executive Officer | 64 | 2015-02-28 |
Paul Lytle
DFI | Director of Finance/CFO | 58 | 2024-01-31 |
Steven D. Reich
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Daniel Schmitt
BRD | Director/Board Member | 64 | 2015-03-31 |
Aaron Fletcher
CHM | Chairman | 46 | 2015-03-31 |
Daniel Zabrowski
BRD | Director/Board Member | 66 | 2021-02-28 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 5/21/26 | Free | Director | 15,000 | 0.0633% | ||
| 5/21/26 | Free | Director | 15,000 | 0.0633% | ||
| 5/21/26 | Free | Director | 15,000 | 0.0633% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.54% | -20.14% | -84.16% | - | 28.23M | |
| -1.82% | +5.03% | +56.71% | +66.69% | 57.28B | |
| -0.27% | +5.74% | +40.26% | +80.17% | 54.99B | |
| -2.05% | -3.31% | +0.75% | +414.39% | 23.18B | |
| +1.97% | -0.43% | -21.00% | -13.67% | 22.59B | |
| -1.13% | +4.54% | +22.73% | -8.06% | 20.46B | |
| +1.57% | +2.09% | +28.01% | -27.56% | 17.56B | |
| -0.10% | +5.57% | +38.63% | +565.16% | 15.67B | |
| +5.29% | 0.00% | +185.09% | +332.66% | 14.46B | |
| +0.79% | -0.20% | +22.39% | +181.58% | 13.92B | |
| Average | +0.25% | -0.35% | +28.94% | +176.82% | 24.01B | |
| Weighted average by Cap. | -0.06% | +1.93% | +39.78% | +137.72% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | - |
| Net income | - | - |
| Net Debt | - | - |
Employees
12
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-27 | US$1.150 | -2.54% | 224,527 |
| 26-07-24 | US$1.180 | -6.35% | 93,561 |
| 26-07-23 | US$1.260 | -0.40% | 118,313 |
| 26-07-22 | US$1.265 | -6.30% | 128,224 |
| 26-07-21 | US$1.350 | -3.57% | 114,704 |
Sell
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
1.180USD
Average target price
9.978USD
Spread / Average Target
+745.55%
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ACTU Stock
Select your edition
All financial news and data tailored to specific country editions
